All Roche articles – Page 2
-
Business
Roche backs biologics boom
Swiss firm to invest heavily in manufacturing for complex biological drugs
-
BusinessTwo way traffic for Chinese drug licensing
Western companies are seeing more value in Chinese innovation
-
Business
Antiviral patents released by Roche
Firm will supply cheap drugs and allow generics in developing countries
-
Business
Data-sharing partnership for drug discovery
Collaborative project aims to assist medicinal chemistry efforts
-
Business
Roche to release Tamiflu trial data
The company will drip feed data to the Cochrane Collaboration, but with some elements redacted
-
Business
$595m octreotide deal grabs Roche
Company will get worldwide rights to oral formulation of growth hormone drug
-
BusinessIndia pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?
-
Business
Roche and the Tamiflu data
Company position on access to data for antiviral Tamiflu (oseltamivir) tablets could be softening
-
FeatureSequencing in the fast lane
Advances in DNA sequencing technology are changing the way scientists look at genomes. Phillip Broadwith gets up to speed with the latest developments
-
Business
Roche rapped for side-effect reporting failure
European medicines regulator names and shames Swiss giant for not disclosing 80,000 instances of potential adverse drug reactions
-
Business
Roche cuts 1000 jobs with US R&D site closure
Streamlining strategy will see oncology and virology research moved to Switzerland and Germany
-
BusinessHDL drug class struggling after latest flop
The failure of another ‘good’ cholesterol-raising drug and a new genetic study casts shadow over HDL hypothesis
- Previous Page
- Page1
- Page2
- Next Page